Market Data

Genetic products maker Affymetrix Inc (NASDAQ:AFFX) recently announced that it has entered into a global distribution agreement with ScreenCell, a medical devices company, which specializes in isolating rare circulatory cells. Under the agreement, Affymetrix will be the sole distributor of ScreenCell’s Circulatory Tumour Cells (“CTC”) Technology, to be used only for research purposes.
Affymetrix has launched the QuantiGene ViewRNA CTC Platform, which combines ScreenCell’s unique isolation … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards